Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43)
The summary for the Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43): This Funding Opportunity Announcement (FOA) solicits Phase I R43 SBIR grant applications from small businesses to develop novel complex 3-dimensional (3-D) in vitro human musculoskeletal and skin tissue models that fit into the NIAMS mission (http://www.niams.nih.gov/About_Us/Mission_and_Purpose/mission.asp). These engineered 3-D human tissue or organ models would provide alternatives to animal models of diseases and animal testing, and enable the study of human tissue physiology and disease pathophysiology in vitro and ultimately lead to better therapies that prevent or cure diseases. Applicants may propose to engineer novel in vitro models and/or develop novel technologies to meet some of the specific challenges in building these models. All applications need to use human cells in the context of in vitro 3-D culture, and must be immediately relevant to NIAMS mission areas. This FOA is not intended to support research using non-human cells or animals. Non-responsive applications will not be reviewed
Federal Grant Title: | Building Complex 3-Dimensional in Vitro Human Musculoskeletal and Skin Tissue Models (R43) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AR-17-005 |
Type of Funding: | Grant |
CFDA Numbers: | 93.846 |
CFDA Descriptions: | Arthritis, Musculoskeletal and Skin Diseases Research |
Current Application Deadline: | Oct 18, 2016 |
Original Application Deadline: | Oct 18, 2016 |
Posted Date: | Jan 19, 2016 |
Creation Date: | Jan 19, 2016 |
Archive Date: | Nov 18, 2016 |
Total Program Funding: | $1,500,000 |
Maximum Federal Grant Award: | $225,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-17-005.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 ...
- • Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 ...
- • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...
- • Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
- • NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
- • Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa)
- • Niams Small Grant Program for New Investigators
- • Skin Diseases Research Core Centers
- More Grants from the National Institutes of Health
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
- • Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...
- • Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...